Topic: contract manufacturer
Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.
Boehringer Ingelheim's leap of faith in China has paid off with the German company's production of a PD-1 for BeiGene.
Teva will produce its new migraine drug at a plant in Israel and more news of note.
Private equity player Ampersand Capital Partners is backing another CDMO, this one targeted at sterile injectables.
South Korea’s JW Pharmaceutical has started targeting emerging markets with a deal for a plant in Vietnam.
South Korea's SK Holdings is rolling three API operations into a new unit, SK Pharmteco, and has put its headquarters in Sacramento, California.
A judge orders Allergan to turn over Botox production details; A U.S. senator urges the FDA to run surprise inspections; the FDA approves Daiichi's cancer drug.
Known for aggressive acquisitions of its own, CDMO Cambrex is now the target of a buyout bid—this time to the tune of $2 billion.
CDMO Fujifilm Diosynth has acquired from Biogen a biologics production facility in Denmark with about 800 employees.
Mylan’s EpiPen has had a troubled few years, and now the auto-injector's manufacturer—Pfizer—may offload its manufacturing contract.